Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers

Introduction. ER, PR, and HER2 are routinely available in breast cancer specimens. The purpose of this study is to contrast breast cancer-specific survival for the eight ER/PR/HER2 subtypes with survival of an immunohistochemical surrogate for the molecular subtype based on the ER/PR/HER2 subtypes a...

Full description

Saved in:
Bibliographic Details
Main Authors: Parise, Carol A., Caggiano, Vincent
Format: Artigo
Language:Inglês
Published: Hindawi Publishing Corporation 2014
Subjects:
Clinical Study
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4058253/
https://ncbi.nlm.nih.gov/pubmed/24955090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/469251
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items